01:43 PM EDT, 06/27/2024 (MT Newswires) -- NLS Pharmaceutics ( NLSP ) said Thursday that preclinical results from in vitro studies targeting alpha-synuclein, specifically the A53T mutation, showed the compounds' potential to treat Parkinson's disease.

Shares surged nearly 42% as intraday trading volume climbed to over 151.3 million versus the stock's daily average of about 6.9 million.

Kala Bio ( KALA ) said Thursday it signed a securities purchase agreement with institutional investors to sell common stock and series H convertible non-redeemable preferred shares in a private placement, targeting gross proceeds of about $12.5 million.

Shares jumped 38% as intraday trading volume at more than 10.6 million compared with a daily average of about 20,000.

Denali Capital Acquisition ( DECA ) said Thursday that it and Longevity Biomedical have mutually agreed to terminate their proposed business combination deal.

Denali said it will seek "alternative ways to consummate an initial business combination."

Shares soared 45%, with intraday trading volume advancing to more than 148,000 from a daily average of about 32,000.

Price: 0.26, Change: +0.08, Percent Change: +41.73